Journals / Turkish Journal of Hematology / 2022 / Cilt: 39 - Sayı: 2

Invasive Fungal Infections in Children with Leukemia: Clinical Features and Prognosis

Lösemili Çocuklarda İnvazif Mantar Enfeksiyonları: Klinik Özellikler ve Prognoz

Pages
94–102
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mean age was significantly older in the IFI group compared to children without IFIs (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The incidence of invasive fungal infections (IFIs) has increased due to intensive chemotherapy in childhood leukemia.
📊
Key Findings & Data:Materials and Methods: The hospital records of 307 children with acute lymphoblastic leukemia (ALL, n=238), acute myeloid leukemia (AML, n=51), and relapsed leukemia (n=18) between January 2010 and December 2015 were retrospectively evaluated.
💡
Conclusion & Impact:The mean age was significantly older in the IFI group compared to children without IFIs (p
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The incidence of invasive fungal infections (IFIs) has increased due to intensive chemotherapy in childhood leukemia. The aim of this study was to evaluate the incidence, risk factors, causative pathogens, and impact on survival of IFIs among pediatric leukemia patients. Materials and Methods: The hospital records of 307 children with acute lymphoblastic leukemia (ALL, n=238), acute myeloid leukemia (AML, n=51), and relapsed leukemia (n=18) between January 2010 and December 2015 were retrospectively evaluated. Results: A total of 1213 febrile neutropenia episodes were recorded and 127 (10.4%) of them were related to an IFI. Of 307 children, 121 (39.4%) developed IFIs. The mean age was significantly older in the IFI group compared to children without IFIs (p

Özet

Amaç: Çocukluk çağı lösemisinde yoğun kemoterapi nedeniyle invaziv mantar enfeksiyonlarının (IFI) insidansı artmıştır. Bu çalışmanın amacı, pediatrik lösemi hastalarında IFI’nın insidansını, risk faktörlerini, nedensel patojenleri ve sağkalım üzerindeki etkisini değerlendirmektir. Gereç ve Yöntemler: Ocak 2010 ile Aralık 2015 tarihleri arasında akut lenfoblastik lösemili (ALL, n=238), akut myeloid lösemili (AML, n=51) ve relaps lösemili (n=18) 307 çocukların hastane kayıtları geriye dönük olarak değerlendirildi. Bulgular: Toplam 1213 febril nötropeni atağı kaydedildi ve bunların 127’si (%10,4) IFI ile ilgiliydi. Bu 307 çocuğun 121’i (%39,4) IFI geliştirdi. Ortalama yaş, IFI grubunda IFI olmayan çocuklara kıyasla anlamlı olarak daha büyük bulundu (p

🔖

Cite This Article

GÜNEŞ, A. M., EVİM, M. S., BAYTAN, B., ERDEM, M., YILMAZ, Ş., HACIMUSTAFAOĞLU, M. K., TÜFEKÇİ, Ö., ÖREN, H., ÇELEBİ, S., ENER, B., ELMAS, K. Ü. (2022). Invasive Fungal Infections in Children with Leukemia: Clinical Features and Prognosis. Turkish Journal of Hematology, Cilt: 39 - Sayı: 2, 94–102. https://ajindex.com/articles/606494

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, Vora A, Baruchel A, Silverman LB, Schmiegelow K, Escherich G, Horibe K, Benoit YC, Izraeli S, Yeoh AE, Liang DC, Downing JR, Evans WE, Relling MV, Mullighan CG. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol 2015;33:2938-2948
  2. Hasle H, Kaspers GJ. Strategies for reducing the treatment-related physical burden of childhood acute myeloid leukaemia - a review. Br J Haematol 2017;176:168-178
  3. Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, Roilides E, Styczynski J, Warris A, Lehrnbecher T; Fourth European Conference on Infections in Leukaemia; Infectious Diseases Working Party of the European Group for Blood Marrow Transplantation (EBMT-IDWP); Infectious Diseases Group of the European Organisation for Research and Treatment of Cancer (EORTC-IDG); International Immunocompromised Host Society (ICHS); European Leukaemia Net (ELN). Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol 2014;15:e327-e340
  4. Ruijters VJ, Oosterom N, Wolfs TFW, van den Heuvel-Eibrink MM, van Grotel MJ. Frequency and determinants of invasive fungal infections in children with solid and hematologic malignancies in a nonallogeneic stem cell transplantation setting: a narrative review. Pediatr Hematol Oncol 2019;41:345-354
  5. Crassard N, Hadden H, Piens MA, Pondarré C, Hadden R, Galambrun C, Pracros JP, Souillet G, Basset T, Berthier JC, Philippe N, Bertrand Y. Invasive aspergillosis in a paediatric haematology department: a 15-year review. Mycoses 2008;51:109-116
  6. Mor M, Gilad G, Kornreich L, Fisher S, Yaniv I, Levy I. Invasive fungal infections in pediatric oncology. Pediatr Blood Cancer 2011;56:1092-1097
  7. Kobayashi R, Kaneda M, Sato T, Ichikawa M, Suzuki D, Ariga T. The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan. J Pediatr Hematol Oncol 2008;30:886-890
  8. Lashkari HP, Fernandes N, Alva K, Rai S. Central nervous system fungal infection and acute lymphoblastic leukemia in children: what is the optimal duration of antifungal therapy? J Pediatr Hematol Oncol 2017;39:e312-e317
  9. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas